|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2006-11-19
|
|
pubmed:abstractText |
Most guidelines do not recommend prostate-specific antigen (PSA) screening in elderly men who have limited life expectancies because the known harms of screening outweigh potential benefits. However, there are no large-scale studies of actual PSA screening practices in elderly men, according to life expectancy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1538-3598
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
296
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2336-42
|
|
pubmed:dateRevised |
2007-11-28
|
|
pubmed:meshHeading |
pubmed-meshheading:17105796-Aged,
pubmed-meshheading:17105796-Aged, 80 and over,
pubmed-meshheading:17105796-Cohort Studies,
pubmed-meshheading:17105796-Health Status,
pubmed-meshheading:17105796-Hospitals, Veterans,
pubmed-meshheading:17105796-Humans,
pubmed-meshheading:17105796-Life Expectancy,
pubmed-meshheading:17105796-Male,
pubmed-meshheading:17105796-Mass Screening,
pubmed-meshheading:17105796-Prostate-Specific Antigen,
pubmed-meshheading:17105796-Prostatic Neoplasms,
pubmed-meshheading:17105796-United States
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
PSA screening among elderly men with limited life expectancies.
|
|
pubmed:affiliation |
Division of Geriatrics, San Francisco VA Medical Center, California, San Francisco 94121, USA. louise.walter@ucsf.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
